The Market Opportunity
A large, underserved market at an inflection point.
The global fetal monitoring market is substantial, growing, and ripe for disruption. Structural shifts in healthcare delivery, accelerated by the post-pandemic telehealth revolution, have created a once-in-a-generation opportunity for a platform that spans both home and hospital.
$5.3B
Total Addressable Market
Global fetal monitoring market projected to reach $9.3B by 2033, driven by a rise in high-risk pregnancies and escalating global standards for prenatal care.
7.2%
CAGR 2026-2033
Consistent above-market growth driven by remote/home monitoring and AI intergration for real-time data analysis.
132M*
Births Per Year Globally
Every birth is an intrapartum monitoring event. Every pregnancy is an antepartum monitoring opportunity. The addressable patient population is universal.
*8.5M in Europe, N.America, Australia
Structural Tailwinds
POST-COVID TELEHEALTH
Permanent shift in payer and patient acceptance of remote care. Home monitoring is now an expectation, not an exception.
RPM REIMBURSEMENT
Expanding Centers for Medicare & Medicaid Services (CMS) and private payer reimbursement for remote patient monitoring (RPM) creates a clear commercial pathway for home-based pregnancy care.
FDA BREAKTHROUGH PATHWAY
Devices addressing unmet needs in maternal and fetal health are well-positioned for expedited FDA review, compressing time to market.
HOSPITAL DECONGESTION
Healthcare systems globally are under financial and political pressure to move appropriate care out of hospital. Maternity is a priority area.
PATIENT EMPOWERMENT
Consumer demand for continuous health data, validated by the wearables market, is rapidly extending into maternal health. Expectant mothers expect more.